Articles tagged with: women

Sep02

Just Released: Updated MPT Product Development Database

Wednesday, 02 September 2020 Written by // Susanna Moore, IMPT Program Associate Tags // contraceptive, innovation, prevention, product development, women

The IMPT recently released its updated MPT Product Development Database. The IMPT Secretariat conducted the annual update process between February and June of 2020 and launched the updated database in July 2020.

Dec19

Forward progress and future goals: End of the year reflections from the IMPT

Thursday, 19 December 2019 Written by // IMPT Secretariat Staff Tags // contraceptive, innovation, prevention, product development, women

The IMPT offices are always a buzz with activity during the months of November and December. Giving Tuesday, World AIDS Day, as well as general end-of-the year wrap ups—it is a reminder that for organizations like ours, this time of year is a time for increased activism, awareness, and reflection. This year, as the IMPT celebrates a decade of progress in the MPT field, we recognize both forward progress and future goals as we continually work to bring MPTs closer to a reality that will improve the lives of women and girls worldwide.

Dec19

Forward progress and future goals: End of the year reflections from the IMPT (Copy)

Thursday, 19 December 2019 Written by // IMPT Secretariat Staff Tags // contraceptive, innovation, prevention, product development, women

The IMPT offices are always a buzz with activity during the months of November and December. Giving Tuesday, World AIDS Day, as well as general end-of-the year wrap ups—it is a reminder that for organizations like ours, this time of year is a time for increased activism, awareness, and reflection. This year, as the IMPT celebrates a decade of progress in the MPT field, we recognize both forward progress and future goals as we continually work to bring MPTs closer to a reality that will improve the lives of women and girls worldwide.

Aug20

An ArcGIS Mapping Tool to Identify MPT Target Populations

Tuesday, 20 August 2019 Written by // Suzanne Ryan-Ibarra, Kyli Gallington, IMPT Secretariat Staff Tags // contraceptive, GIS mapping, HIV, women

In sub-Saharan Africa, adolescent girls and young women are at the highest risk of acquiring HIV. However, as this is a heterogeneous population, the characteristics of these women can vary greatly. A one-size-fits-all approach simply will not work. In order for MPTs to have the greatest impact, approaches must be tailored to the populations where they are most likely to be successful.

Jul22

FROM THE PIPELINE | Fast track to an MPT: Development of a dual-purpose pill containing oral PrEP and an oral contraceptive

Monday, 22 July 2019 Written by // Barbara Friedland Series // From the Pipeline Tags // contraceptive, dual-purpose, pill, Population Council, prevention, women

Imagine if women could take one pill every day and be protected from unintended pregnancy AND HIV? 

And what if this pill was available within several years? 

We believe the fastest route to a contraceptive MPT is to combine two products that are ALREADY ON THE MARKET into a single pill.

A dual-purpose pill has the potential to play an important role in helping women protect themselves against both unintended pregnancy and HIV infection.

The Population Council is working with partners to fast-track development of dual- purpose pill

[12 3 4  >>  
The IMPT is the first & only initiative dedicated to advancing the field of multipurpose prevention technologies (MPTs), products that combine HIV prevention, other STI prevention, and contraception.

IMPT Secretariat
1750 Howe Avenue, Suite 550
Sacramento, CA 95825
IMPT@cami-health.org

The Initiative for Multipurpose Prevention Technologies (IMPT) is a project of CAMI Health, a social impact organization dedicated to improving the health of women and their families worldwide. CAMI Health is housed at the Public Health Institute (PHI).

This project is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of Cooperative Agreement #AID-OAA-A-16-00045. The contents are the responsibility of the IMPT, CAMI Health, PHI, and its partners and do not necessarily reflect the views of USAID or the U.S. Government.
© Copyright 2020, Public Health Institute / CAMI Health / IMPT Secretariat. All rights reserved.